PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-29.67%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would suspect a firm-specific problem if peers maintain profit growth.
5.08%
D&A growth of 5.08% while Healthcare median is zero at 0.00%. Walter Schloss would question intangible or new expansions driving that cost difference.
99.06%
Deferred tax growth of 99.06% while Healthcare median is zero at 0.00%. Walter Schloss would see a difference that might matter for future cash flow if significant.
179.35%
SBC growth of 179.35% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or staff additions causing more equity grants.
285.27%
Working capital of 285.27% while Healthcare median is zero at 0.00%. Walter Schloss would check if expansions or cost inefficiencies cause that difference.
-100.00%
AR shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage in working capital if sales do not drop.
100.00%
Inventory growth of 100.00% while Healthcare median is zero at 0.00%. Walter Schloss would question if expansions or new product lines require extra stock.
100.00%
AP growth of 100.00% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or credit policies affecting the difference.
-100.00%
Other WC usage shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage if top-line is stable or growing.
-1179.06%
Other non-cash items dropping yoy while Healthcare median is 0.00%. Seth Klarman would see a short-term advantage if real fundamentals remain intact.
412.48%
Positive CFO growth while Healthcare median is negative at -10.91%. Peter Lynch would see a notable cash advantage in a challenging sector environment.
-1123.65%
CapEx declines yoy while Healthcare median is 0.00%. Seth Klarman would note a short-term FCF advantage if revenue is stable.
No Data
No Data available this quarter, please select a different quarter.
25.87%
Purchases growth of 25.87% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or new strategic positions driving the difference.
No Data
No Data available this quarter, please select a different quarter.
729.29%
Growth of 729.29% while Healthcare median is zero at 0.00%. Walter Schloss questions intangible or special projects explaining that difference.
-295.26%
Reduced investing yoy while Healthcare median is 0.00%. Seth Klarman sees potential advantage in near-term liquidity if revenue remains stable.
No Data
No Data available this quarter, please select a different quarter.
9863.41%
Issuance growth of 9863.41% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or acquisitions financed by new shares.
No Data
No Data available this quarter, please select a different quarter.